South Africa MDEL Application Process: Fees, Timelines and Annual Compliance

1. Key takeaways

The application process for a South African medical device Establishment Licence (MDEL) runs as follows: confirm the scope of activities and the licence type, appoint an Authorised Representative (AR), assemble the application dossier, submit the application together with the prescribed fee, undergo SAHPRA review and, where applicable, inspection, and after approval pay the licence issuance fee before collecting the licence. The standard processing cycle is widely observed in industry to be approximately 6 to 8 weeks. Expedited handling, which historically applied to specific situations such as devices and IVDs involved during the COVID-19 pandemic, targeted completion within 10 to 15 working days and allowed only two rounds of deficiency correction. Note that these figures are a practical estimate: South African legislation does not prescribe a statutory working-day deadline for licence review.

Three structural features define this process. First, the review timeline carries inherent uncertainty because no statutory limit exists. Second, the payment proof accompanies the application and the application fee is non-refundable. Third, approval is not the end of the compliance journey: the licence is valid for 5 years, an annual retention fee must be paid before the last working day of June each year, and late payment can lead to cancellation of the licence.

2. Legal basis

The table below lists the official sources on which this article rests, including the instrument number, publication date and the specific provisions relied upon.

3. Expert insights

Insight 1: South Africa has no statutory licence review deadline, and this is the fundamental scheduling uncertainty. Unlike Macao, China, where published timeframes specify a formality check of 20 working days and decision periods of 70 or 100 working days, Notice 1515 does not prescribe any statutory number of working days for licence applications. This means the 6 to 8 weeks figure is an industry observation rather than a legal commitment. When planning a project, companies must treat it as an estimate subject to fluctuation and must avoid making delivery commitments to customers based on this timeline. Contract clauses that promise a licence date by a fixed calendar day create avoidable commercial exposure, because the regulator is under no obligation to meet any external schedule.

Insight 2: The expedited pathway is a historical arrangement, not an entitlement. Expedited processing, with a target of 10 to 15 working days, was applied in specific public health situations and carried the condition that only two rounds of deficiency correction are permitted. This condition itself reveals the substance of expedited handling: the review is not faster; instead, the number of correction rounds is compressed. A company that hopes to use the fast lane must therefore submit a complete, well-organised dossier at first submission. If core documents are missing, the two-round limit will be exhausted before the file is even complete, and the application will fall back into the standard queue with time lost.

Insight 3: The payment proof is a precondition of review, not an afterthought. The application must be accompanied by proof of payment, and the application fee is not refundable. Incomplete payment information, such as omitting the applicant name, telephone number or application number as a reference, means the funds cannot be matched to a specific application. In practice, delays caused by unmatched payments are often longer than delays caused by document deficiencies, because the finance query, bank confirmation and re-submission of proof each consume additional cycles before the file is even accepted for substantive processing.

Insight 4: A separate licence issuance fee falls due before the certificate is collected. After the licence is approved, the issuance fee must be paid before collection. This is a second official charge, independent of the application fee, and budgets that only account for the application fee will underestimate the cost of obtaining the licence. Fees follow the current SAHPRA tariff and may be adjusted annually. Companies should therefore re-check the published tariff at the time of application rather than relying on figures quoted in earlier correspondence or in internal budget templates prepared in previous years.

Insight 5: Approval immediately opens an annual compliance cycle. The licence is valid for 5 years, but the annual retention fee must be paid before the last working day of June each year, and overdue payment can result in cancellation of the licence. Obtaining the certificate therefore marks entry into a recurring annual compliance obligation, not the finish line. The practical consequence is administrative: a standing calendar reminder, a named owner of the payment task and a documented reconciliation of proof of payment should be established on the day the licence is granted, so that the first annual cycle does not depend on institutional memory.

4. Practical recommendations

The following actions align day-to-day preparation with the process features described above.

1. Reserve 6 to 8 weeks plus a fluctuation buffer in the schedule, and never convert the industry observation into a binding delivery promise to a customer.
2. Assemble the dossier completely at first submission: because the expedited pathway allows only two correction rounds, document quality determines whether speed is even achievable.
3. Make the payment reference complete: state the applicant name, telephone number and application number, and submit the payment proof as a separate document.
4. Budget for the licence issuance fee in addition to the application fee, checking the current SAHPRA tariff at the time of filing.
5. Set up an annual retention fee reminder on the day of approval, with payment completed before the June deadline each year.
6. Retain the acknowledgement of receipt and all correspondence for later reference during changes, renewal and inspections.

5. Verification checklist

Confirm every item below before and shortly after submission.

• □ Scope of activities and required licence type have been confirmed
• □ The Authorised Representative (AR) has been appointed, with CV and letter of appointment prepared
• □ The application form (GLF-MD-06A v5) has been completed and signed by the AR on every page
• □ Proof of payment has been submitted separately with complete reference information
• □ The company is aware that the application fee is non-refundable
• □ The licence issuance fee has been budgeted (payable after approval and before collection)
• □ The schedule reserves 6 to 8 weeks plus a buffer, with no commitments made against this timeline
• □ A reminder mechanism for the annual retention fee has been established

Regulatory information verified as of 29 October 2026. The regulations, guidance and effective dates described in this article are limited to the official sources listed in the legal basis section above, as published on that date. Where official documents are subsequently updated, the latest published version prevails.

• South Africa local resources: GRZAN assists manufacturers from the Chinese mainland and overseas with SAHPRA medical device Establishment Licence (MDEL) applications and product registration preparation, including Authorised Representative (AR) scheme design, ISO 13485 certification pathway planning and CAB selection, GMDN coding and classification determination, technical documentation preparation, and the establishment of vigilance and adverse event reporting mechanisms.
• Service capabilities: product attribute determination and risk classification (Class A/B/C/D), establishment licence application and renewal, reliance pathway justification, technical documentation and Essential Principles conformity argumentation, labelling and instructions-for-use localisation (English), and post-market vigilance and annual compliance information submission support.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.